COVID-19

© Lais Depieri / Getty Images

Synbiotic supplementation may ease long COVID: RCT

By Stephen Daniells

Supplementation with a prebiotic-probiotic combination may help with some long COVID problems such as fatigue, memory, concentration and gastrointestinal upset, says a new large study from Hong Kong.

GettyImages - upper respiratory tract infection / Mohammed Haneefa Nizamudeen

Study: URTI symptoms reduced with PEA Levagen+

By Olivia Haslam

An industry funded study concludes the branded palmitoylethanolamide (PEA) ingredient ‘Levagen+’ is safe and effective in reducing the incidence and symptoms associated with upper respiratory tract infections (URTIs).

GettyImages - Man with Covid-19 / Justin Paget

Intake of plant compounds linked to lower COVID-19 risk

By Olivia Haslam

Individuals who consume higher amounts of specific plant-derived compounds, such as polyphenols and particular types of lignans and phytosterols, are at a reduced risk of contracting COVID-19, a new study by authors from Poland has concluded.

Getty

Vitamin D improves outcomes of hospitalised COVID-19 patients

By Olivia Brown

A new study finds that supplementation with 25(OH) vitamin D in an Italian cohort of hospitalised COVID-19 patients that were deficient, resulted in a reduced length of hospital stay compared to those who were not supplemented.

Getty

COVID:19: L-carnitine supplement may have protective effect

By Olivia Brown

A new RCT has found that the L-carnitine supplement Carnipure tartrate can increase platelet counts in patients testing positive for COVID-19, suggesting it may have a protective effect against thrombosis-induced complications.

Getty

The evidence on supplements for COVID-19 immunity

By Olivia Brown

Vitamin D, zinc, and selenium supplements have significant evidence to suggest intakes reduce the risk of COVID-19 infection and associated severe outcomes, whilst probiotics may enhance symptomatic and viral clearance.

Pura Collagen on success amid Brexit, pandemic

Pura Collagen on success amid Brexit, pandemic

By Danielle Masterson

Just as the UK entered a new trading relationship with the EU, the economy was thrown another curveball with the pandemic. But with a little strategic foresight and a lot of humor, Jennifer Mo is taking the situation in stride.

© MarkgrafAve / Getty Images

PEA may improve outcomes for Covid-19: Study

By Nicola Gordon-Seymour

Palmitoylethanolamide (PEA) may reduce inflammation and optimise immune responses to infectious conditions such as Covid-19, according to researchers in the USA.

Getty Images / ljubaphoto

BMJ studies that discount vitamin D in COVID fight draw ire

By Danielle Masterson

Researchers and stakeholders are reacting to new research that contradicts two previous meta-analyses of randomized clinical trials that found vitamin D to have a protective shield against respiratory illnesses.

©Getty Images - Oakozhan

Continued pandemic issues in China hit Usana hard

By Hank Schultz

Usana health Sciences recorded steep declines in revenue as the company has been blasted by pandemic-related dislocations in mainland China and other markets, the company’s largest market.

Clinical support for low-cost tablets to treat coronavirus

Clinical support for low-cost tablets to treat coronavirus

By Nicola Gordon-Seymour

Chewable tablets or capsules formulated with dextrose or sorbitol and added bovine lactoferrin (bFL) offer a low cost and easy to produce preventative or clinical treatment for coronavirus strains, including COVID-19, according to a new study.

Getty Images / Phichaklim1

Hemp compounds block COVID-19, study finds

By Danielle Masterson

Researchers found that a pair of cannabinoid acids bind to the SARS-CoV-2 spike protein, preventing a critical step in the process the virus uses to infect people.

Follow us

Products

View more

Webinars